James Feldman

Q: What is James Feldman's success rate?

James Feldman currently has a success rate of 97.02343709316771.

Q: What is the average return of James Feldman's calls?

Their stock ratings have generated an average return of 10.237264994427676.

Wells Fargo | Real Estate

James Feldman is an analyst from Wells Fargo specializing in the Real Estate sector. Ranked #1407 out of 4558 analysts, they have issued 49 stock ratings with a success rate of 97.02% and an average return of 10.24%.

James Feldman has a well-established track record, with 49 ratings issued in the Real Estate sector. They have consistently delivered a success rate of 97.02% and an average return of 10.24%, underscoring their expertise and ability to identify winning opportunities for investors.

#1407

Out of 4558

Total Ratings

+97.02%

Success Rate

+10.24%

Average Return

Recent Ratings Analysis

SUI

Buy

Feb 27, 2026

Target

$150.00

Current

$136.46

Performance

0.00%

James Feldman rated SUI as Overweight on Feb 27, 2026, setting a price target of 150. Shares have remained stable near 136.46, leaving the 150 target still in play.

ELS

Hold

Feb 27, 2026

Target

$70.00

Current

$67.16

Performance

0.00%

On Feb 27, 2026, ELS was given a Equal-Weight rating by James Feldman, with a target price of 70. Market indecision, reflected in sideways trading near 67.16, supported the cautious call.

AMH

Buy

Nov 25, 2025

Target

$38.00

Current

$30.00

Performance

-6.51%

AMH received a Overweight rating from James Feldman on Nov 25, 2025, aiming for 38. The rating hasn’t played out as hoped, with the stock trading 6.51% below expectations.

MAA

Buy

Nov 25, 2025

Target

$157.00

Current

$133.86

Performance

-0.89%

On Nov 25, 2025, James Feldman published a Overweight outlook on MAA, with a target of 157. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 133.86.

CPT

Hold

Nov 25, 2025

Target

$111.00

Current

$108.34

Performance

2.03%

James Feldman on Nov 25, 2025 assigned CPT a Equal-Weight rating, with a price target of 111. The Hold stance reflected consolidation, as shares held near 108.34.

UDR

Buy

Nov 10, 2025

Target

$39.00

Current

$37.50

Performance

8.48%

On Nov 10, 2025, James Feldman reaffirmed UDR with a Overweight rating, targeting 39. The recommendation was supported by strong follow-through as the stock rose from 37.5 to 37.5.

EQR

Hold

Nov 10, 2025

Target

$62.00

Current

$63.21

Performance

6.22%

EQR was rated Equal-Weight by James Feldman on Nov 10, 2025, with a price objective of 62. Despite caution, upside momentum rewarded risk-takers with gains to 63.21.

AVB

Buy

Nov 10, 2025

Target

$193.00

Current

$177.23

Performance

0.27%

On Nov 10, 2025, James Feldman initiated coverage on AVB with a Overweight rating and target of 193. Neutral price movement of 0.27% leaves room for interpretation.

ESS

Hold

Nov 10, 2025

Target

$268.00

Current

$255.11

Performance

-1.94%

James Feldman issued a Equal-Weight recommendation for ESS on Nov 10, 2025, price target set at 268. The rating was appropriate for a consolidating market trading near 255.11.

KRG

Buy

Oct 21, 2025

Target

$25.00

Current

$26.05

Performance

13.95%

On Oct 21, 2025, KRG was evaluated by James Feldman, who gave a Overweight rating and target of 25. This case illustrates how a timely bullish rating can translate into tangible gains of 13.95%.

FRT

Buy

Oct 21, 2025

Target

$113.00

Current

$108.77

Performance

8.49%

James Feldman rated FRT as Overweight on Oct 21, 2025, setting a price target of 113. The call has proven timely, with shares rising 8.49% toward the price target of 113.

IVT

Buy

Oct 21, 2025

Target

$33.00

Current

$31.20

Performance

9.32%

On Oct 21, 2025, IVT was given a Overweight rating by James Feldman, with a target price of 33. The stock rallied 9.32% after the rating, narrowing the gap to the target of 33 and validating the bullish stance.

REG

Buy

Oct 21, 2025

Target

$82.00

Current

$79.00

Performance

9.48%

REG received a Overweight rating from James Feldman on Oct 21, 2025, aiming for 82. Momentum has favored the Buy call, with shares climbing from 79 to 79, rewarding those who trusted the recommendation.

SLG

Hold

Oct 17, 2025

Target

$61.00

Current

$36.85

Performance

-29.93%

On Oct 17, 2025, James Feldman published a Neutral outlook on SLG, with a target of 61. Weakness in the stock, now at 36.85, supported the conservative rating.

INVH

Hold

Oct 13, 2025

Target

$31.00

Current

$26.34

Performance

-6.76%

James Feldman on Oct 13, 2025 assigned INVH a Equal-Weight rating, with a price target of 31. The call successfully avoided chasing as shares lost 6.76%.

RHP

Buy

Aug 27, 2025

Target

$114.00

Current

$98.75

Performance

-0.55%

On Aug 27, 2025, James Feldman reaffirmed RHP with a Overweight rating, targeting 114. Market indecision has kept the 114 target in a holding pattern.

APLE

Hold

Aug 27, 2025

Target

$13.00

Current

$12.26

Performance

-6.91%

APLE was rated Equal-Weight by James Feldman on Aug 27, 2025, with a price objective of 13. Investors who stayed cautious avoided some of the 6.91% decline.

BRX

Hold

Aug 27, 2025

Target

$28.00

Current

$30.27

Performance

7.91%

On Aug 27, 2025, James Feldman initiated coverage on BRX with a Equal-Weight rating and target of 28. The Hold stance underestimated the stock’s strength as it gained 7.91%.

DRH

Hold

Aug 27, 2025

Target

$9.00

Current

$10.04

Performance

16.88%

James Feldman issued a Equal-Weight recommendation for DRH on Aug 27, 2025, price target set at 9. A neutral call gave way to stronger-than-expected performance, closing in on 9.

HST

Buy

Aug 27, 2025

Target

$19.00

Current

$19.59

Performance

12.78%

On Aug 27, 2025, HST was evaluated by James Feldman, who gave a Overweight rating and target of 19. This case illustrates how a timely bullish rating can translate into tangible gains of 12.78%.

PEB

Hold

Aug 27, 2025

Target

$11.00

Current

$12.83

Performance

14.15%

James Feldman rated PEB as Equal-Weight on Aug 27, 2025, setting a price target of 11. Despite the Hold call, shares climbed 14.15% to 12.83, revealing unexpected momentum.

PK

Hold

Aug 27, 2025

Target

$12.00

Current

$11.31

Performance

-5.36%

On Aug 27, 2025, PK was given a Equal-Weight rating by James Feldman, with a target price of 12. The rating provided protection from downside risk as the stock fell to 11.31.

XHR

Buy

Aug 27, 2025

Target

$15.00

Current

$15.28

Performance

7.08%

XHR received a Overweight rating from James Feldman on Aug 27, 2025, aiming for 15. Momentum has favored the Buy call, with shares climbing from 15.28 to 15.28, rewarding those who trusted the recommendation.

AHH

Sell

Aug 25, 2025

Target

$7.00

Current

$6.25

Performance

-12.10%

On Aug 25, 2025, James Feldman published a Underperform outlook on AHH, with a target of 7. The Sell recommendation underestimated bullish momentum toward 7.

SHO

Hold

Jul 01, 2025

Target

$8.50

Current

$9.28

Performance

4.98%

James Feldman on Jul 01, 2025 assigned SHO a Equal-Weight rating, with a price target of 8.5. The Hold stance reflected consolidation, as shares held near 9.28.

RLJ

Sell

Jul 01, 2025

Target

$7.00

Current

$8.02

Performance

7.08%

On Jul 01, 2025, James Feldman reaffirmed RLJ with a Underweight rating, targeting 7. The Sell recommendation anticipated weakness, as shares dropped 7.08%.

ELME

Hold

Feb 20, 2025

Target

$19.00

Current

$2.15

Performance

-87.42%

ELME was rated Equal-Weight by James Feldman on Feb 20, 2025, with a price objective of 19. Investors who stayed cautious avoided some of the 87.42% decline.

CTRE

Buy

Oct 01, 2024

Target

$34.00

Current

$40.62

Performance

31.75%

On Oct 01, 2024, James Feldman initiated coverage on CTRE with a Overweight rating and target of 34. The stock’s climb of 31.75% since the call highlights the foresight in the rating.

WELL

Hold

Oct 01, 2024

Target

$135.00

Current

$207.12

Performance

62.35%

James Feldman issued a Equal-Weight recommendation for WELL on Oct 01, 2024, price target set at 135. A neutral call gave way to stronger-than-expected performance, closing in on 135.

GLPI

Hold

Aug 26, 2024

Target

$51.00

Current

$48.91

Performance

-4.15%

On Aug 26, 2024, GLPI was evaluated by James Feldman, who gave a Equal-Weight rating and target of 51. Hold sentiment was validated by subdued trading with no breakout beyond 48.91.

EPRT

Buy

Aug 26, 2024

Target

$34.00

Current

$33.94

Performance

7.51%

James Feldman rated EPRT as Overweight on Aug 26, 2024, setting a price target of 34. The call has proven timely, with shares rising 7.51% toward the price target of 34.

EPR

Sell

Aug 26, 2024

Target

$45.00

Current

$59.41

Performance

24.92%

On Aug 26, 2024, EPR was given a Underweight rating by James Feldman, with a target price of 45. The Sell stance aligned with downward action, with the stock sliding from 59.41 to 59.41.

WPC

Hold

Aug 26, 2024

Target

$62.00

Current

$74.65

Performance

24.33%

WPC received a Equal-Weight rating from James Feldman on Aug 26, 2024, aiming for 62. Investors saw gains of 24.33% that the cautious stance didn’t fully capture.

O

Hold

Aug 26, 2024

Target

$62.00

Current

$67.00

Performance

8.47%

On Aug 26, 2024, James Feldman published a Equal-Weight outlook on O, with a target of 62. The Hold call missed some of the bullish momentum as shares advanced toward 62.

Frequency Asked Questions

Who is James Feldman?

James Feldman is an analyst from Wells Fargo specializing in the Real Estate sector.

What is James Feldman's success rate?

James Feldman currently has a success rate of +97.02%.

How many ratings has James Feldman issued?

James Feldman has issued 49 stock ratings so far.

What is the average return of James Feldman's calls?

Their stock ratings have generated an average return of +10.24%.

What is James Feldman's ranking?

James Feldman is ranked #1407 out of 4558 analysts.

What types of ratings does James Feldman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow James Feldman?

You can follow James Feldman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by James Feldman?

Their latest rating was a Buy on SUI issued on 2026-02-27.